GE Healthcare
GE Healthcare Precision Oncology Pacts Focus on Cracking Data Silos, Improving Patient Outcomes
Premium
GE recently inked deals with Sophia Genetics, the University of Cambridge, and Optellum to improve early diagnosis of cancer with genomics and AI.
GE Healthcare, University of Cambridge Team on AI-Based Precision Oncology
Building on earlier work supported by the Mark Foundation for Cancer Research and Cancer Research UK, the partners will create an app to aggregate and analyze clinical, genomic, and imaging data.
Sophia Genetics Q3 Revenues Increase 44 Percent
Net loss for the bioinformatics firm, which went public in July, more than doubled year over year during the third quarter to $10.2 million.
Sophia Genetics Files for $100M IPO, Inks Cancer Data Deal With GE Healthcare
Sophia, which will trade on the Nasdaq, seeks to raise $100 million in an IPO, and separately announced a partnership with GE Healthcare.
The Syntax instrument, available later this year, will initially be able to make batches of 96 oligos of 60-mer length at a time with same-day turnaround.